NDC11 73043001314
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 73043-0013-14 | 73043-0013 |
| 73043-013-14 | 73043-013 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Temozolomide | TEMOZOLOMIDE | Devatis, Inc. | 6b263fe0-5f06-4889-bf14-4aa185470810 | 2024-11-30 | Warnings, Adverse reactions | 73043-013-14 73043-013 73043001314 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.